Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking. 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 
AUSTIN, Texas, Dec. 01, 2015 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and BioElectronics Corporation (OTC Pink:BIEL), the maker of advanced consumer pain management medical devices, announced today that a new audio interview with the Company, is now available. The interview can be heard at http://smallcapvoice.com/blog/11-25-15-smallcapvoice-interview-with-bioelectronics-corp-biel
Rick Staelin, Chairman of the Board, BioElectronics Corporation (BIEL) called in to SmallCapVoice.com, Inc. to go over his Company’s explosive sales growth and the drivers behind that growth. In BIEL’s last quarter they reported 216% increase in sales over the same quarter a year ago ($499,869 versus $231,174). For the nine months ending September 30 they’re up 248 percent ($1,678,665 versus $677,454).
Rick Staelin stated, “I enjoyed talking about innovative marketing program that that we used to launch ActiPatch into the UK market. This program allowed us to greatly expand our distribution as well as sales, even though we started out with almost no brand awareness and a skeptical consumer base.”
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.
About BioElectronics Corporation
BioElectronics Corporation is the maker of a leading family of affordable, disposable, drug-free, medical devices. ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; HealFast® Therapy and the Allay® Menstrual Pain Therapy. Please visit www.bielcorp.com for more information.
Paul Knopick 940.262.3584 [email protected] For SmallCapVoice.com Stuart T. Smith 512-267-2430 [email protected]
